Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 82

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 85
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
close
Save to Existing Project
Save to a New Project
AGNICE
Mitelos Bioscience,S.L. Spain flag Spain
Abstract ID:
AGNICE is a dietary supplement adjunct to traditional therapies that addresses those factors involved in acne vulgaris, named inflammation, sebum production and bacterial proliferation....
Contact Joaquim Colomé
Participants
You
Email me a copy of this message

AGNICE is an adjunct modality to first-line acne vulgaris therapies. Its ingredients (whey protein complex, mineral and vitamins) allow taking a better care against blemishes thanks to their anti-inflammatory, anti-oxidant, sebum regulating, bacteriostatic properties supported with extensive scientific evidence and EFSA claims.

The pharmaceutical form is granules with pleasant fruity flavor and packed in 20 sachets. Each sachet contains 3g and the recommended dose is one sachet per day.

FEATURED
Last Updated May 2016
Technology Type THERAPEUTIC
Phase of Development REGISTERED / FDA APPROVED / FINISHED PRODUCT
CORPORATION